Insulin-stimulated glucose uptake by the glucose transporter GLUT4 plays a central role in whole-body glucose homeostasis, dysregulation of which leads to type 2 diabetes. However, the molecular components and mechanisms regulating insulin-stimulated glucose uptake remain largely unclear. Here, we demonstrate that Axin interacts with the ADP-ribosylase tankyrase 2 (TNKS2) and the kinesin motor protein KIF3A, forming a ternary complex crucial for GLUT4 translocation in response to insulin. Specific knockdown of the individual components of the complex attenuated insulin-stimulated GLUT4 translocation to the plasma membrane. Importantly, TNKS2−/− mice exhibit reduced insulin sensitivity and higher blood glucose levels when re-fed after fasting. Mechanistically, we demonstrate that in the absence of insulin, Axin, TNKS and KIF3A are co-localized with GLUT4 on the trans-Golgi network. Insulin treatment suppresses the ADP-ribosylase activity of TNKS, leading to a reduction in ADP ribosylation and ubiquitination of both Axin and TNKS, and a concurrent stabilization of the complex. Inhibition of Akt, the major effector kinase of insulin signaling, abrogates the insulin-mediated complex stabilization. We have thus elucidated a new protein complex that is directly associated with the motor protein kinesin in insulin-stimulated GLUT4 translocation.
Glucose homeostasis is tightly governed by multiple levels of regulation, involving many different molecules, cell types and hormones. GLUT4, one type of glucose transporter, is predominantly expressed in skeletal muscles and adipose tissues, and serves as a major mediator of insulin-stimulated glucose uptake in these tissues1,2,3,4. In the basal state, GLUT4 is sequestered in intracellular membrane compartments known as GLUT4 storage vesicles (GSVs) formed from either endosomes or the trans-Golgi network (TGN). When blood glucose levels are elevated, insulin secretion is heightened, stimulating glucose uptake into adipocytes and muscle cells by inducing rapid translocation of GLUT4 vesicles to the cell membrane. The main established pathway for insulin-stimulated GLUT4 translocation involves the activation of the insulin receptor and the two downstream kinases PI3K5,6 and Akt7. Combined depletion of Akt1 and Akt2 markedly attenuates the effect of insulin on GLUT4 movement, in which Akt2 plays a prominent role8 as mice lacking Akt2 exhibit insulin resistance and a diabetes mellitus-like syndrome9. Insulin-mediated GLUT4 translocation is also dependent on the microtubule network10,11, which motor proteins such as kinesins can use as a track12 for GSV trafficking. However, the role of microtubule-based cytoskeleton in GLUT4 trafficking remains controversial13,14,15,16. The kinesin proteins known to participate in anterograde GSV transport include KIF5B17 and KIF318. KIF3 consists of KIF3A and KIF3B, forming the kinesin-2 subfamily of the kinesin superfamily, which is linked to cargo vesicles by the kinesin-associated protein18.
The tankyrase (TRF1-interacting ankyrin-related ADP-ribose polymerase, TNKS) protein family consists of two members, tankyrase 1 (TNKS1) and tankyrase 2 (TNKS2), which share 85% identity in amino-acid sequences19. Both proteins contain a poly-ADP-ribosyl polymerase (PARP) domain. TNKS1/2 have been shown to interact with insulin-responsive aminopeptidase (IRAP)20, which is one of the integral membrane proteins in GLUT4 vesicles21 and may play important roles in the maintenance and sorting of insulin-responsive GLUT4 vesicles22,23. It was reported that TNKS1 enhanced insulin-stimulated exocytosis of GLUT424. TNKS1-deficient mice exhibit various metabolic changes including abnormality in glucose metabolism25, and TNKS2−/− mice show growth retardation26. Unfortunately, double-knockout mice are embryonically lethal19, which has hindered the analysis of the combined roles of both TNKS in glucose homeostasis. Possibility exists that TNKS1 and TNKS2 are functionally redundant to each other, which may explain the uncompromised overall glucose intake in TNKS1-deficient mice25. Evidence in support of a possible role of TNKS1 in controlling glucose homeostasis also includes that TNKS1 is a candidate gene for diabetes in humans, based on its location in the chromosomal locus of 8p23.1 that contains susceptibility genes for a subset of monogenic forms of type 2 diabetes27. The role of TNKS2 in glucose homeostasis is not clear.
Axin was originally identified as a key inhibiting factor in the Wnt pathway by serving as a central scaffold for the assembly of the degradation complex of β-catenin28. We have identified additional pathways regulated by Axin that are stress-related, including the JNK cascade29 and DNA damage response30,31,32. Moreover, Axin interacts with DCAP (Drosophila homolog of CAP), a component of the glucose transport regulatory complex, suggesting that Axin may play a role in insulin-mediated glucose transport33. Functional linkage between Axin and TNKS came from one study showing that the PARP activity of TNKS mediates PARsylation of Axin and subsequently enhances its ubiquitination and degradation34. Down-regulation of Axin by TNKS elevates the level of β-catenin, leading to the stimulation of Wnt signaling34.
We have identified, by yeast two-hybrid screens, a series of signaling molecules that interact with Axin, including Daxx, HIPK2 and Pirh2 that are key regulators of the tumor suppressor p5330,31,32. Among the other clones was the one that encodes tankyrase 2 (TNKS2). To elucidate the biological function of the interaction between Axin and TNKS2, we carried out another round of yeast two-hybrid screen using TNKS2 as the bait. As a result, we identified KIF3A, a kinesin motor protein, as a novel TNKS2-interacting protein. Here we report that Axin, TNKS and KIF3A form a ternary complex that is required for insulin-stimulated GLUT4 redistribution to the cell surface to increase glucose uptake.
Axin forms a ternary complex with TNKS2 and KIF3A
To search for molecular cues for the physiological function of the Axin/TNKS interaction, a yeast two-hybrid screen was carried out using the ankyrin domain (residues 648-937) of TNKS2 as the bait. Interestingly, 19 identified candidate clones encode KIF3A, an essential component of the motor protein kinesin-2. The C-terminal fragment of aa 494-CT is common to all the 19 overlapping KIF3A clones identified. To confirm this interaction, we performed immunoprecipitation (IP) experiments. As shown in Figure 1A, KIF3A was co-precipitated with TNKS by the antibody for endogenous TNKS. We then investigated whether Axin may also bind to KIF3A. Indeed, KIF3A appeared in the immunoprecipitate of Axin, indicating that Axin can also interact with KIF3A (Figure 1B). The TNKS/KIF3A and Axin/KIF3A interactions were also supported by IP using over-expressed tagged proteins in 293T cells (Supplementary information, Figure S1A). Furthermore, we employed in vitro pull-down assays to examine the direct interaction between TNKS2 and KIF3A, and between Axin and KIF3A. GST-KIF3A could be pulled down by His-tagged TNKS2 (Figure 1C) and by His-tagged Axin (Figure 1D). To address whether Axin, TNKS2 and KIF3A could co-exist in the same complex, we carried out a two-step co-IP, and found that they could form a ternary complex in the cell (Figure 1E). When the three proteins were co-expressed, Axin and KIF3A could be simultaneously detected in the precipitate of FLAG-tagged TNKS2 (Supplementary information, Figure S1B). Notably, over-expression of Axin could increase the amount of KIF3A co-precipitated with TNKS2 (Supplementary information, Figure S1B). This suggests that Axin could promote the association between TNKS2 and KIF3A. We then knocked down Axin by infecting adipocytes with adenovirus-siAxin, and carried out co-IP using the anti-TNKS antibody. As predicted, co-precipitated KIF3A was decreased (Supplementary information, Figure S1C). All these results suggest that, within the ternary complex, each component simultaneously binds to the other two partners, with Axin directly interacting with both TNKS2 and KIF3A, TNKS2 with Axin and KIF3A, and KIF3A with Axin and TNKS2.
The Axin/TNKS2/KIF3A complex is critical for GLUT4 translocation in response to insulin
Since KIF3A has been shown to function in microtubule-associated GLUT4 translocation and TNKS1/2 interact with IRAP, an integral protein of GLUT4 vesicles, we set out to determine whether the Axin/TNKS/KIF3A complex participates in insulin-stimulated GLUT4 translocation. First, we carried out immunofluorescent staining in differentiated 3T3-L1 adipocytes as the cells express high levels of GLUT4. We found that Axin, TNKS and KIF3A are co-localized in the perinuclear region of adipocytes (Figure 2A), and that Axin and KIF3A are partially co-localized with the TGN marker TGN38 (Figure 2B). Importantly, TNKS, KIF3A and Axin show co-staining with GLUT4 (Figure 2C). These results indicate that, in the absence of insulin, the Axin/TNKS/KIF3A complex co-localizes with GLUT4 (Figure 2C). In the presence of insulin, we observed a dramatic redistribution of GLUT4 to the cell surface (Figure 2C). However, insulin treatment did not enrich Axin, TNKS or KIF3A to the cell membrane (Figure 2A-2C, Supplementary information, Figure S2).
We next determined the effects of knockdown of the Axin/TNKS/KIF3A complex on insulin-stimulated translocation of GLUT4 by immunofluorescence microcopy (Figure 3A). The results show that depletion of each component of the Axin/TNKS/KIF3A complex impaired insulin-stimulated GLUT4 translocation, in line with the previous observation that microinjection of anti-KIF3 adaptor subunit (KAP) or anti-KIF3B antibody into adipocytes attenuated GLUT4 translocation18. Next, we prepared the plasma membrane fraction of untreated and insulin-stimulated adipocytes that were infected with siRNA-delivering adenoviruses targeting Axin (Figure 3B) or TNKS (Figure 3C) and assessed the relative amounts of the GLUT4 protein in the PM fractions and in the post-PM fractions (supernatants, clear of PM) by immunoblotting. The PM content of GLUT4 after insulin stimulation was drastically decreased in Axin- or TNKS-knockdown cells compared to adipocytes expressing control siRNA, whereas the overall expression of GLUT4 was not affected. Insulin receptor β-subunit (IR-β), which is located on the cell membrane, was detected as a marker for the prepared PM fractions. Double knockdown of TNKS1 and TNKS2 further decreased insulin-stimulated GLUT4 translocation to the PM than single knockdown (Supplementary information, Figure S4). The above data collectively indicate that the complex assembled by Axin, TNKS and KIF3A is important in promoting GLUT4 translocation in response to insulin.
Axin/TNKS/KIF3A complex is required for insulin-stimulated glucose uptake
We then assessed whether the Axin/TNKS/KIF3A complex affects glucose uptake by knocking down the expression of Axin, TNKS1/2 or KIF3A individually in 3T3-L1 adipocytes by siRNA-expressing adenoviruses. As can be seen from Figure 4A-4C and Supplementary information, Figure S3, depletion of Axin, KIF3A or TNKS2 attenuated insulin-stimulated 2-deoxyglucose uptake. Re-introduction of each protein by adenoviruses expressing human Axin, TNKS2 and KIF3A restored the insulin-stimulated glucose uptake. Double knockdown of TNKS1 and TNKS2 further decreased insulin-stimulated glucose uptake than single knockdown (Figure 4D, Supplementary information, Figure S3C), indicating that TNKS1 and TNKS2 have possibly overlapping functions in the regulation of glucose uptake in adipocytes. Furthermore, we knocked down TNKS2 and KIF3A together and found that the effect on glucose uptake was similar to that of KIF3A single knockdown (Figure 4E), suggesting that TNKS and KIF3A work in conjunction to regulate insulin-stimulated glucose uptake.
We next determined the physiological consequence of TNKS regulation of GLUT4 translocation. We measured the blood glucose levels of adult (12-week-old) wildtype and TNKS2−/− mice at normally fed, fasted and re-fed states (Figure 5A), and found that the normally fed and fasted TNKS2−/− mice had similar blood glucose levels compared to WT mice. However, the blood glucose levels were significantly higher in the re-fed (fed after fasting) TNKS2−/− mice (9.06 ± 0.33 mM) compared to wildtype littermates (7.68 ± 0.26 mM, P = 0.043). The food consumption between wildtype and TNKS2−/− mice showed no significant difference (Supplementary information, Figure S5). Intriguingly, we observed increased blood glucose levels in normally fed 7-week-old TNKS2−/− mice (8.33 ± 0.19 mM) compared to WT mice of the same age (7.2 ± 0.29 mM, P = 0.012) (Figure 5B). Moreover, glucose tolerance test (GTT) showed that adult TNKS2−/− mice had higher levels of blood glucose following administration of an exogenous load of glucose compared with that of WT mice (Figure 5C), suggesting a decreased glucose disposal in the TNKS2-deficient mice. Insulin secretion was similar between the WT and TNKS2−/− mice, at either fasted or fed state (Figure 5D). In fact, in the GTT test, due to elevated blood glucose levels in TNKS2−/− mice, their secreted insulin level was proportionally increased (Supplementary information, Figure S6), indicating that the decreased glucose disposal observed in TNKS2−/− mice during the GTT assay is not caused by an abnormal insulin secretion. Following injection of excessive amounts of insulin for the insulin tolerance test (ITT), TNKS2−/− mice showed higher blood glucose levels compared to WT mice (Figure 5E). These results collectively indicate that TNKS2 plays an important role in mediating insulin-stimulated glucose uptake in vivo.
Insulin stabilizes Axin/TNKS/KIF3A complex by suppressing TNKS PARsylase activity
We next assessed whether the Axin and TNKS proteins are dynamically modulated before and after insulin treatment. As shown in Figure 6A, insulin treatment increased cellular levels of Axin and TNKS, which is not due to altered mRNA abundance as indicated by quantitative RT-PCR analysis (Supplementary information, Figure S7A and S7B). Since TNKS1/2 PARsylate themselves and Axin, increasing their ubiquitination and subsequent degradation34, we next determined the extents of PARsylation and ubiquitination of TNKS and Axin in the presence or absence of insulin. 3T3-L1 adipocytes were serum-starved for 4 h, followed by insulin treatment in the presence of MG132 (Figure 6B). Axin and TNKS proteins were then immunoprecipitated and the effects of insulin on their PARsylation and ubiquitination were separately monitored by immunoblotting using anti-PAR and anti-ubiquitin (Ub) antibodies. The results showed that insulin treatment obviously reduced both PARsylation and ubiquitination of TNKS and Axin, indicating that the TNKS PARsylase activity was suppressed upon insulin stimulation. We also checked whether GLUT4 is PARsylated or ubiquitinated with or without the treatment of insulin. The results show that GLUT4 is indeed PARsylated and ubiquitinated. However, the PARsylation and ubiquitination as well as the total GLUT4 protein levels are not affected by insulin treatment (Supplementary information, Figure S8).
We then tested whether levels of the Axin/TNKS/KIF3A complex formation were changed with addition of insulin by carrying out co-IP of the endogenous complex proteins from 3T3-L1 adipocytes treated with or without insulin with the antibody against TNKS. Increased amounts of KIF3A and Axin were co-precipitated with TNKS in cells treated with insulin (Figure 6C). We also investigated Axin/TNKS/KIF3A complex formation in C2C12 cells through co-IP (Supplementary information, Figure S9), which showed that the complex formation is conserved between adipocytes and muscle cells.
To support the notion that the Axin/TNKS/KIF3A complex is stabilized by insulin through inhibition of TNKS PARsylase activity, we synthesized the TNKS PARsylase inhibitor XAV939. As shown in Supplementary information Figure S10A, XAV939 could promote the tripartite complex formation. Furthermore, XAV939 could increase insulin-stimulated glucose uptake by about 30% (Supplementary information, Figure S10B) and enhance insulin-simulated GLUT4 translocation to the PM (Supplementary information, Figure S10C). Together, these findings suggest that insulin stimulation can enhance the Axin/TNKS/KIF3A complex formation by suppressing TNKS-mediated PARsylation and subsequent ubiquitination/degradation of Axin and TNKS itself.
Akt mediates insulin-stimulated Axin/TNKS/KIF3A complex stabilization
To further analyze the direct involvement of insulin signaling in modulating the complex of Axin/TNKS/KIF3A, we determined the effects of Akt inhibition on the abundance of these proteins and on their interaction in cells treated with or without insulin by IP and western blotting analysis. As can be seen from Figure 7A, while insulin treatment increased the protein levels of Axin and TNKS, and the co-IP of KIF3A with TNKS, Akt inhibitor VIII (for both Akt1 and Akt2) abrogated such increases. Mechanistically, Akt acts to suppress PARsylase activity of TNKS, because treatment with the Akt inhibitor reversed the effect of insulin on PARsylation and subsequent ubiquitination of TNKS (Figure 7B). Moreover, we carried out co-IP experiments to check if insulin treatment could increase the association of the complex with microtubules and GLUT4 vesicles. Increased levels of TNKS were detected in the GLUT4 immunoprecipitate (Supplementary information, Figure S11), and tubulin and KIF3A were more abundantly co-present in the TNKS immunoprecipitate (Supplementary information, Figure S12), from insulin-treated cells.
In the present study, we have demonstrated that Axin, TNKS and KIF3A form a multimeric complex that mediates insulin–stimulated GLUT4 translocation and glucose uptake. Remarkably, both Axin and TNKS are directly linked to KIF3A, a critical component of KIF3 known to be necessary for GLUT4 translocation. We have also provided multiple lines of evidence to demonstrate that this complex is directly involved in glucose transport by promoting GLUT4 translocation, at least in part from the Golgi origin, to the surface membrane in response to insulin. First of all, although normally fed adult TNKS2−/− mice show little change in blood glucose levels, the normally fed young TNKS2−/− mice have significantly higher blood glucose levels compared to the wildtype littermates. Second, adult re-fed TNKS2−/− mice display a significant increase in blood glucose levels. GTT and ITT assays also show that the decline of blood glucose in TNKS2−/− mice was slower following injection of excessive glucose or insulin. When Axin, TNKS and KIF3A were knocked down individually by siRNA in 3T3-L1 adipocytes, insulin-induced GLUT4 translocation and glucose uptake were obviously impaired. We knocked down TNKS and KIF3 together and found that the effect on glucose uptake was similar to that of KIF3A single knockdown, suggesting that TNKS and KIF3A work in conjunction to regulate insulin-stimulated glucose uptake. Third, immunofluorescence staining experiments revealed co-localization of the complex components with GLUT4 as well as with the Golgi apparatus in the perinuclear region. TNKS has been shown to interact with IRAP20, further suggesting a functional linkage of the Axin/TNKS complex to glucose transport.
It is worthy to note that insulin signaling diverges to intersect with GLUT4 trafficking via multiple routes. Both PI3K-dependent and PI3K-independent pathways operate in the insulin-induced GLUT4 translocation1,4. Genetic or pharmacologic disruption of Akt inhibits only about two-thirds of the signaling to GLUT48,35,36. Since the Axin/TNKS/KIF3A complex is regulated in an AKT-dependent manner, the partial effect of the TNKS2 knockout on glucose disposal is therefore not unexpected. In particular, we have provided evidence supporting a functional overlap between TNKS1 and TNKS2, as shown in glucose uptake assays.
Based on the data from our current study and from others, it is clear that in the absence of insulin, TNKS proteins poly-ADP-ribosylate themselves and Axin, leading to their degradation. Insulin signaling suppresses the PARsylase activity of TNKS in an Akt-dependent manner to stabilize the Axin/TNKS/KIF3A complex. By virtue of its simultaneous interaction with both TNKS and KIF3A, Axin serves as a scaffold to facilitate the formation of the ternary complex in the presence of insulin, which may promote the complex to associate with GLUT4 vesicles to enable their ultimate translocation to the PM (Figure 7C). The observation that treatment with the TNKS PARsylase inhibitor XAV939 could increase the complex formation, GLUT4 translocation, and insulin-stimulated glucose uptake further underscores the importance of PARsylase activity in the regulation of glucose uptake. Together, we have uncovered a functional linkage between the Axin/TNKS complex and the kinesin motor for GLUT4 translocation in response to insulin, in which the PARsylase activity plays a negative role in controlling the stability of the translocation complex. However, it remains unclear how insulin-activated Akt signals to the Axin complex to trigger GLUT4 translocation to the cell surface. It has been shown that Akt can phosphorylate AS160, leading to derepression of the small G protein Rabs for GLUT4 trafficking37,38,39,40,41,42. The functional interrelationship between the Axin/TNKS/KIF3A complex and Akt-mediated regulation of AS160 awaits further investigation.
Materials and Methods
CMV2-FLAG-TNKS2 (human) was kindly provided by Dr Chi NW. It was tagged with three tandem HA epitopes fused to the N-terminus and cloned to pCMV5 vector. Full-length cDNA encoding mouse KIF3A was obtained from an EST clone (IMAGE No. 601205534, Open Biosystem).
RNA interference and adenovirus infection
Adenovirus vector pAdEasy (GFP) was used for expression of siRNA. mTNKS1: 5′-IndexTermGAGATGCAGAGCACTATTC-3′; mTNKS2: 5′-IndexTermGGAAGGATGTAGTTGAAT A-3′; mAxin1: 5′-IndexTermGGAGAGAAGGAGATCAGTA-3′; mKIF3A: 5′-IndexTermAGCTAAAATGTGTGG CCTA-3′. 3T3-L1 cells were induced to differentiate into adipocytes and on day 6 were infected with individual adenovirus. After 48 h of infection, adipocytes were subjected into experiments.
293T and 3T3-L1 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 IU penicillin and 100 mg/ml streptomycin at 37 °C in a humidified incubator containing 5% CO2. Differentiation of 3T3-L1 cells was initiated at day 2 post-confluence by addition of 5 μg/ml of insulin, 1 μM dexamethasone (DEX), and 0.5 mM 3-isobutyl-1-methylxanthine (IBMX) for 2 d, followed by culturing in DMEM supplemented with 10% FBS and 5 μg/ml insulin for additional 2 d. The differentiated cells were then maintained in normal culture medium.
In vivo PARsylation
cells were serum starved in low glucose DMEM (1 g/l glucose, Hyclone) for 4 h, and then treated with 20 μM MG132 accompanied with or without 200 nM insulin for 30 min. Cells were harvested with RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 1 mM EDTA, 1 μM leupeptin, 1 μM PMSF) supplemented with 1% SDS. Cleared cell lysates were diluted with RIPA buffer to reduce the SDS concentration to 0.2% and subjected to IP using the antibodies indicated and protein A/G beads overnight, followed by western blotting.
Yeast two-hybrid screen
Yeast two-hybrid screen of a mouse brain cDNA library was carried out using MATCHMAKER GAL4 Two-Hybrid System 3 (Clontech) according to the manufacturer's instructions as described previously31. The sequence of aa 648-937 encompassing the ankyrin-repeat and SAM domain of human tankyrase 2 (TNKS2) was used as the bait.
Antibodies and drugs
Rabbit polyclonal anti-Axin antibodies C2b and C8b were raised as described previously30. Commercial antibodies used in this study include mouse anti-HA (F-7), anti-Myc (9E10), goat anti-Axin (S-20), rabbit anti-tankyrase1/2 (H350), goat anti-GLUT4 (C20), rabbit anti-TGN38 (M-290) and mouse anti-ubiquitin (P4D1) (Santa Cruz Biotechnology), rabbit anti-GLUT4 antibody (ab654, Abcam), mouse anti-FLAG antibody (M2 antibody, Sigma), mouse anti-KIF3A (BD Transduction Laboratories), and rabbit anti-KIF3A antibody (Abcam). Bovine insulin,IBMX, and DEX were purchased from Sigma, and Akt inhibitors VIII from Calbiochem.
3T3-L1 cells were differentiated to adipocytes and plated on 22-mm2 coverslips in six-well plates. After serum starvation for 4 h, adipocytes were treated with or without 200 nM insulin for 30 min, followed by fixation as previously described32. Cells were then incubated with indicated primary antibodies in blocking solution overnight at 4 °C. Next, cells were washed four times with PBS containing 0.02% Triton X-100, 1.5% BSA and 1 mM NaN3, incubated with 4 μg/ml of bovine anti-goat Texas red, donkey anti-mouse Alexa Fluor 488, goat anti-rabbit Alexa Fluor 647 in blocking solution for 2 h. Cells were then washed and stained with DAPI (1 μg/ml) in PBS for 5 min.
Glucose uptake assay
3T3-L1 cells grown in 12-well plates and were induced to differentiate to adipocytes. Mature adipocytes (8 d) were serum starved for 4 h, incubated with or without 200 nM insulin for 20 min and then subjected to a 2-deoxy-D-glucose (2-DG) (0.25 μCi 3H-2DG per well) (Perkin Elmer). 10 min later, after three times washes, cells were lysed and intracellular 2-DG, which cannot be metabolized, was measured by liquid scintillation counting.
Plasma membrane isolation
According to the protocol described in43, 3T3-L1 adipocytes were collected and broken by passing through a 25-gauge needle in a hypotonic buffer (50 mM Tris-HCl, pH 8.0, 0.1% NP-40, 0.5 mM DTT, protease inhibitors and phosphatase inhibitors). After centrifugation at 1 000× g for 10 min, the supernatant was collected. The pellet was washed two times with hypotonic buffer without NP-40 and lysed in a buffer (50 mM Tris-HCl, pH 8.0, 1% NP-40, 0.5 mM DTT, protease inhibitors and phosphatase inhibitors) for 1 h at 4 °C. The re-suspended pellet was then centrifuged at 16 000× g for 20 min. The supernatant was collected as the PM fraction. The supernatant collected from the first centrifugation was cleared by centrifugation at 16 000× g for 20 min, and the resulting supernatant was collected as Post-PM fraction.
GTT and ITT
For GTT, mice after overnight fast (16 h) were intraperitoneally injected with D-Glucose (2 g/kg), and blood glucose concentrations were determined at 0, 15, 30, 60, 120 min after injection. In ITT, animals that had been fasted for 4 h were administrated by intraperitoneal injection of human insulin (1 U/kg) and blood glucose levels were determined at the indicated times with Accu-check (Roche).
Bryant NJ, Govers R, James DE . Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 2002; 3:267–277.
Hou JC, Pessin JE . Ins (endocytosis) and outs (exocytosis) of GLUT4 trafficking. Curr Opin Cell Biol 2007; 19:466–473.
Klip A . The many ways to regulate glucose transporter 4. Appl Physiol Nutr Metab 2009; 34:481–487.
Leney SE, Tavare JM . The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J Endocrinol 2009; 203:1–18.
Martin S, Haruta T, Morris A, Klippel A, Williams L, Olefsky J . Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem 1996; 271:17605–17608.
Clarke JF, Young PW, Yonezawa K, Kasuga M, Holman JD . Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J 1994; 300:631–635.
Ng Y, Ramm G, Lopez, JA, James DE . Rapid activation of Akt2 is sufficient to stimulate GLUT4 translocation in 3T3-L1 adipocytes. Cell Metab 2008; 7:348–356.
Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, Czech MP . Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci USA 2003; 100:7569–7574.
Cho H, Mu J, Kim JK, Thorvaldsen JL, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001; 292:1728–1731.
Fletcher LM, Welsh GI, Oatey PB, Tavare JM . Role for the microtubule cytoskeleton in GLUT4 vesicle trafficking and in the regulation of insulin-stimulated glucose uptake. Biochem J 2000; 352(Part 2):267–276.
Huang J, Imamura T, Babendure JL, Lu JC, Olefsky JM . Disruption of microtubules ablates the specificity of insulin signaling to GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem 2005; 280:42300–42306.
Hirokawa N, Noda Y, Tanaka Y, Niwa S . Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol 2009; 10:682–696.
Emoto M, Langille SE, Czech MP . A role for kinesin in insulin-stimulated GLUT4 glucose transporter translocation in 3T3-L1 adipocytes. J Biol Chem 2001; 276:10677–10682.
Fletcher LM, Welsh GI, Oatery PB, Tavare JM . Role for the microtubule cytoskeleton in GLUT4 vesicle trafficking and in the regulation of insulin-stimulated glucose uptake. Biochem J 2000; 352:267–276.
Olson AL, Trumbly AR, Gibson GV . Insulin-mediated GLUT4 translocation is dependent on the microtubule network. J Biol Chem 2001; 276:10706–10714.
Molero JC, Whitehead JP, Meerloo T, James DE . Nocodazole inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes via a microtubule-independent mechanism. J Biol Chem 2001; 276:43829–43835.
Semiz S, Park JG, Nicoloro SM, et al. Conventional kinesin KIF5B mediates insulin-stimulated GLUT4 movements on microtubules. EMBO J 2003; 22:2387–2399.
Imamura T, Huang J, Usui I, Satoh H, Bever J, Olefsky JM . Insulin-induced GLUT4 translocation involves protein kinase C-lambda-mediated functional coupling between Rab4 and the motor protein kinesin. Mol Cell Biol 2003; 23:4892–4900.
Chiang YJ, Hsiao SJ, Yver D, et al. tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. PLoS One 2008; 3:e2639.
Chi NW, Lodish HF . tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles. J Biol Chem 2000; 275:38437–38444.
Keller SR, Scott HM, Mastick CC, et al. Cloning and characterizatin of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles. J Biol Chem 1995; 270:23612–23618.
Keller SR, Davis AC, Clairmont KB . Mice deficient in the insulin-regulated membrane aminopeptitase show substantial decreases in glucose transporter GLUT4 levels but maintain normal glucose homeostasis. J Biol Chem 2002; 277:17677–17686.
Jordens I, Molle D, Xiong W, Keller SR, McGraw TE . Insulin-regulated aminopeptidase is a key regulator of GLUT4 trafficking by controlling the sorting of GLUT4 from endosomes to specialized insulin-regulated vesicles. Mol Biol Cell 2010; 21:2034–2044.
Yeh TY, Sbodio JI, Tsun ZY, Luo B, Chi NW . Insulin-stimulated exocytosis of GLUT4 is enhanced by IRAP and its partner tankyrase. Biochem J 2007; 402:279–290.
Yeh TY, Beiswenger KK, Li P, et al. Hypermetabolism, hyperphagia, and reduced adiposity in tankyrase-deficient mice. Diabetes 2009; 58:2476–2485.
Chiang YJ, Nguyen ML, Gurunathan S, et al. Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice. Mol Cell Biol 2006; 26:2037–2043.
Pezzolesi MG, Nam M, Nagase T, et al. Examination of candidate chromosomal regions for type 2 diabetes reveals a susceptibility locus on human chromosome 8p23.1. Diabetes 2004; 53:486–491.
Li Z, Francois F, Tong Z, et al. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997; 90:181–192.
Rui, Y, Xu Z, Xiong B, et al. A beta-catenin-independent dorsalization pathway activated by Axin/JNK signaling and antagonized by Aida. Dev Cell 2007; 13:268–282.
Rui Y, Xu Z, Lin S, et al. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. EMBO J 2004; 23:4583–4594.
Li Q, Wang X, Wu X, et al. Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death. Cancer Res 2007; 67:66–74.
Li Q, Lin S, Wang X, et al. Axin determines cell fate by controlling the p53 activation threshold after DNA damage. Nat Cell Biol 2009; 11:1128–1134.
Yamazaki H, Nusse R . Identification of DCAP, a drosophila homolog of a glucose transport regulatory complex. Mech Dev 2002; 119:115–119.
Huang SM, Mishina YM, Liu S, et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 2009; 461:614–620.
Bae SS, Cho H, Mu J, Birnbaum MJ . Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 2003; 278:49530–49536.
Gonzalez E, McGraw TE . Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the PM. Mol Biol Cell 2006; 17:4484–4493.
Sano H, Kane S, Sano E, et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 2003; 278:14599–14602.
Kane S, Sano H, Liu SC, et al. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem 2002; 277:22115–22118.
Zeigerer A, McBrayer MK, McGraw TE . Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol Biol Cell 2004; 15:4406–4415.
Miinea CP, Sano H, Kane S, et al. AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain. Biochem J 2005; 391:87–93.
Kramer HF, Witczak CA, Taylor EB, Fujii N, Hirshman MF, Goodyear LJ. . AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle. J Biol Chem 2006; 281:31478–31485.
Thong FS, Bilan PJ, Klip A . The Rab GTPase-activating protein AS160 integrates Akt, protein kinase C, AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 2007; 56:414–423.
Nishiumi S, Ashida H . Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane. Biosci Biotechnol Biochem 2007; 71:2343–2346.
We thank Dr Chi NW for providing the CMV2-FLAG-TNKS2 (human) construct. This work was supported by grants from the National Basic Research Program of China (2011CB910800 to SCL), the National Natural Science Foundation of China (31130016 to SCL, 30921005 to SCL, and 30970613 to QL), NCET-09-0675 (to QL), and the Science Planning Program of Fujian Province (2009J06021 to QL).
( Supplementary information is linked to the online version of the paper on the Cell Research website.)
Complex formation of ectopically expressed Axin, TNKS, and KIF3A. (PDF 318 kb)
Insulin treatment enriches GLUT4 but not Axin, TNKS or KIF3A on the plasma membrane in adipocytes. (PDF 152 kb)
Knockdown efficiency of siRNAs. (PDF 150 kb)
Knockdown of both TNKS1 and TNKS2 further decreases insulin-stimulated GLUT4 translocation to plasma membrane than single knockdown of TNKS1 or TNKS2. (PDF 297 kb)
Food consumption of Wildtype and TNKS2−/− mice. (PDF 46 kb)
Insulin secretion in GTT test. Wildtype and TNKS2−/− mice were fasted overnight (16 h). (PDF 117 kb)
Cellular mRNA levels of TNKS1/2, Axin, and KIF3A are not changed following insulin treatment. (PDF 91 kb)
PARsylation and ubiquitination of GLUT4. (PDF 56 kb)
Insulin stimulates TNKS complex formation in C2C12. (PDF 89 kb)
XAV939 increased the complex formation, insulin stimulated glucose uptake and GLUT4 translocation. (PDF 203 kb)
Insulin increased association between GLUT4 and TNKS. (PDF 60 kb)
Enhanced binding of TNKS complex to tubulin upon insulin stimulation. (PDF 84 kb)
About this article
Cite this article
Guo, HL., Zhang, C., Liu, Q. et al. The Axin/TNKS complex interacts with KIF3A and is required for insulin-stimulated GLUT4 translocation. Cell Res 22, 1246–1257 (2012). https://doi.org/10.1038/cr.2012.52
- GLUT4 translocation
Medicinal Chemistry Research (2021)
Pleiotropic roles of tankyrase/PARP proteins in the establishment and maintenance of human naïve pluripotency
Experimental Cell Research (2020)
Cellular and Molecular Life Sciences (2020)
An AMPK/Axin1-Rac1 signaling pathway mediates contraction-regulated glucose uptake in skeletal muscle cells
American Journal of Physiology-Endocrinology and Metabolism (2020)
Trends in Cell Biology (2020)